Several recent findings suggested that CHK1 inhibitor-treated human tumor cells hyperactivate ATM, ATR, and caspase-2 after g-radiation and trigger a caspase-2-dependent apoptotic program 51, 52. The gene discussed is CHEK1; the disease is neoplasm.